Houston-based GoCo.io has acquired a company that aims to improve the work-from-home employee experience. Courtesy of GoCo

A Houston software startup has made a strategic acquisition to account for the increasingly large number of companies employing a remote-first workforce.

After closing a $15 million series B funding round last year, GoCo.io, an HR solutions software platform, has acquired WFHomie, a platform that helps remote-first companies enhance the employee experience as well as keep up with people analytics. According to GoCo research, most HR professionals report that they are being asked to retain top talent — employee engagement programs are key to driving that retention, the company says in a news release.

“We know that employee experience is top of mind for SMBs and the HR teams that support them,” says Nir Leibovich, co-founder and CEO of GoCo, in the release. “Our team and our platform are growing rapidly in support of our mission to empower HR professionals, and this acquisition is a key step in that direction.

"It’s clear that the leadership of WFHomie share our vision, passion, and excitement for creating innovative products that help companies build better workplaces," he continues. "We’re confident that the WFHomie team will bring the expertise and agility we need to ship new products and expand our service offerings in line with that vision.”

The details of the transaction were not disclosed. The WFHomie team will be on boarded at GoCo.

Founded in November of 2020 in direct response to the pandemic, Toronto-based WFHomie raised $1.6 million in seed funding in 2021.

“Nir and the leadership team at GoCo are dedicated to building a future where HR and People Ops leaders have the bandwidth to support their employees effectively and create thriving, high-performing workplaces” says Pavla Bobosikova, co-founder and CEO of WFHomie in the news release. “We share the same vision – to improve work-life for employees, while empowering organizations to operate more effectively.”

Founded in 2015 by Leibovich, Jason Wang, and Michael Gugel, GoCo has raised $27.5 million to date and has over 100 employees, according to LinkedIn.

Following a $7 million raise, Houston-based GoCo is looking to grow. Courtesy of GoCo

Houston B-to-B tech startup gears up for growth following $7 million Series A

Serious series

A Houston startup looking to digitize the human resources industry just completed a reassuring round of funding. GoCo closed its Series A funding round led by ATX Seed Ventures alongside UpCurve, Inc. at $7 million.

GoCo, which was founded by CEO Nir Leibovich, Chief Technology Officer Jason Wang, and Chief Product Officer Michael Gugel, is out to bring the much-maligned HR tasks into the digital world. The funding round brings GoCo's total funding to $12.5 million. Leibovich said the new capital will be allocated to hiring across all departments, further platform development to extend the breadth of offerings and to broadly expand the company's customer base.

"Today, we have 6,200 customers across the U.S. and around the world," Leibovich tells InnovationMap. "And we have 25 employees. We're looking to double and triple — if not quadruple — that across 2019."

The company has a solid partnership network with employee benefit insurance agencies like OneDigital and PayneWest, and general agencies like Word & Brown, to offer GoCo's technology as an enhancement to their existing insurance benefits services clients. GoCo also auto-syncs with leading payroll providers ADP, PayChex, Paylocity, Intuit Quickbooks and more, thus uniquely enabling businesses to maintain their benefits broker and payroll provider by integrating with GoCo's platform.

"This Series A and the potential addition of UpCurve's distribution channel to reach hundreds-of-thousands of new customers continues our mission to free SMBs and HR professionals from outdated and tedious administrative burdens. When these professionals look at current HR and benefits solutions on the market and think 'there must be a better way,' we are the better way," says Leibovich. "We want to be synonymous with modern and streamlined HR."

GoCo is backed by additional investments from Salesforce Ventures, Corp Strategics, GIS Strategic Ventures, the venture arm of Guardian Life Insurance, and Digital Insurance, the largest employee benefits-only company in the US. ATX Seed Ventures is investing for the second time.

"We are doubling down on our investment in GoCo, as it is positioned to become the platform of choice for HR professionals to break out of the chains of outdated and complex HR duties, and empowers them to spend more time on their employees and higher value tasks," says Chris Shonk, managing partner at ATX Seed Ventures, in a release. "GoCo is simply the best platform solution to do all this, and their increasing customer base supports it."

Founded in 2015, GoCo is the fusion of modern, paperless HR functions like employee onboarding, secure cloud-storage document management, eSignature workflows, time-off tracking and HR data reporting. As well, it is paired with simplified benefits enrollment and management, payroll sync and HR compliance enablement. The web and mobile based app empower employers to give employees 24/7 access to the full spectrum of a company's HR and benefits offerings.

GoCo creates platforms to onboard employees, conduct training and myriad HR tasks which, said Leibovich, free up HR personnel to handle the business of actually working with employees to grow their potential and assist companies with their missions.

"Typically, HR has lagged behind when it comes to embracing technology," says Leibovich. "Sales, marketing, development, these are places where it's become the norm to seek out tech solutions to problems. With human resources, many firms are still using that paperwork model, and often, a new hire's first day on the job – and therefore their first impression of a company — is filling out forms."

Leibovich had founded two companies before, one based in analytics that they sold to Zinga, the other a biotech firm. It was the biotech venture that brought the Austin-based trio to Houston. Looking around the landscape, Leibovich said he and his partners liked the fact that Houston was a city on the move, with a highly skilled workforce and companies keen on finding tech solutions to their challenges. The city's "if you can dream it, you can do it here" vibe kept the group here as they launched GoCo. Leibovich said he thinks that, in terms of its startup ventures, Houston is where Austin was 10 years ago. And he believes that continued successes in the tech and startup culture will breed more success in the Bayou City.

"This is an ecosystem that is coming together to attract even more talent for ventures like this," he said. "Funding is going to ramp up, and we see Houston as a place where we — and other companies — can create something really special. This is a great place to do business."

All-in-one platform

Courtesy of GoCo

GoCo is the fusion of modern, paperless HR functions like employee onboarding, secure cloud-storage document management, eSignature workflows, time-off tracking and HR data reporting.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Nominations are now open for the 2025 Houston Innovation Awards

Calling All Innovators

Calling all Houston innovators: The Houston Innovation Awards return this fall to celebrate the best and brightest in the Houston innovation ecosystem right now.

Presented by InnovationMap, the fifth annual Houston Innovation Awards will take place November 5 at TMC Helix Park.

The awards program will honor the top startups and innovators in Houston across 10 categories, and we're asking you to nominate the most deserving Houston innovators and innovative companies today.

This year's categories are:

  • Minority-founded Business, honoring an innovative startup founded or co-founded by BIPOC or LGBTQ+ representation.
  • Female-founded Business, honoring an innovative startup founded or co-founded by a woman.
  • Energy Transition Business, honoring an innovative startup providing a solution within renewables, climatetech, clean energy, alternative materials, circular economy, and beyond.
  • Health Tech Business, honoring an innovative startup within the health and medical technology sectors.
  • Deep Tech Business, honoring an innovative startup providing technology solutions based on substantial scientific or engineering challenges, including those in the AI, robotics, and space sectors.
  • Startup of the Year (People's Choice), honoring a startup celebrating a recent milestone or success. The winner will be selected by the community via an interactive voting experience.
  • Scaleup of the Year, honoring an innovative later-stage startup that's recently reached a significant milestone in company growth.
  • Incubator/Accelerator of the Year, honoring a local incubator or accelerator that is championing and fueling the growth of Houston startups.
  • Mentor of the Year, honoring an individual who dedicates their time and expertise to guide and support budding entrepreneurs.
  • Trailblazer, honoring an innovator who's made a lasting impact on the Houston innovation community.

Nominations may be made on behalf of yourself, your organization, and other leaders in the local innovation scene. The nomination period closes on August 31, so don't delay — nominate today at this link, or fill out the embedded form below.

Our panel of esteemed judges will review the nominations, and determine the finalists and winners. Finalists will be unveiled on September 30, and the 2025 Houston Innovation Awards winners will be announced live at our event on November 5.

Tickets will go on sale this fall. Stay tuned for that announcement, as well as more fanfare leading up to the 2025 Houston Innovation Awards.

Nominate now:

Interested in Innovation Awards sponsorship opportunities? Please contact sales@innovationmap.com.

MD Anderson launches $10M collaboration to advance personalized cancer treatment tech

fighting cancer

The University of Texas MD Anderson Cancer Center and Japan’s TOPPAN Holdings Inc. have announced a strategic collaboration to co-develop TOPPAN Holdings’ 3D cell culture, or organoid, technology known as invivoid.

The technology will be used as a tool for personalized cancer treatments and drug screening efforts, according to a release from MD Anderson. TOPPAN has committed $10 million over five years to advance the joint research activities.

“The strategic alliance with MD Anderson paves a promising path toward personalized cancer medicine," Hiroshi Asada, head of the Business Innovation Center at TOPPAN Holdings, said in a news release.

Invivoid is capable of establishing organoid models directly from patient biopsies or other tissues in a way that is faster and more efficient. Researchers may be able to test a variety of potential treatments in the laboratory to understand which approach may work best for the patient, if validated clinically.

“Organoids allow us to model the three-dimensional complexity of human cancers in the lab, thus allowing us to engineer a powerful translational engine—one that could not only predict how patients will respond to therapy before treatment begins but also could help to reimagine how we discover and validate next-generation therapies," Dr. Donna Hansel, division head of pathology and laboratory medicine at MD Anderson, added in the news release. “Through this collaboration, we hope to make meaningful progress in modeling cancer biology for therapeutic innovation.”

The collaboration will build upon preclinical research previously conducted by MD Anderson and TOPPAN. The organizations will work collaboratively to obtain College of American Pathologists (CAP) and Clinical Laboratory Improvement Amendments (CLIA) certifications for the technology, which demonstrate a commitment to high-quality patient care. Once the certifications are obtained, they plan to conduct observational clinical studies and then prospective clinical studies.

“We believe our proprietary invivoid 3D cell culture technology, by enabling the rapid establishment of organoid models directly from patient biopsies, has strong potential to help identify more effective treatment options and reduce the likelihood of unnecessary therapies,” Asada added in the release. “Through collaboration on CAP/CLIA certification and clinical validation, we aim to bring this innovation closer to real-world patient care and contribute meaningfully to the advancement of cancer medicine."